| RS2471561228 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471561343 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471562057 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471562112 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471562154 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471562505 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471573386 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2471573874 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471575135 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471579611 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471579649 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2471580423 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2471581983 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471583750 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471584370 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471584748 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471585091 |
MITF
|
Health Risk |
Pathogenic/Likely pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471585421 |
CRTAP
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471585496 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471585529 |
CRTAP
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2471591500 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471591650 |
MITF
|
Health Risk |
Likely pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471593362 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2471593660 |
MYD88
|
Health Risk |
Pathogenic |
Pyogenic bacterial infections due to MyD88 deficiency, Pyogenic bacterial infections due to MyD88 deficiency |
| RS2471597566 |
THRB
|
Health Risk |
Pathogenic |
Generalized resistance to thyroid hormone, Generalized resistance to thyroid hormone |
| RS2471598456 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS2471598592 |
MITF
|
Health Risk |
Likely pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471599633 |
THRB
|
Health Risk |
Pathogenic |
Selective pituitary resistance to thyroid hormone, Selective pituitary resistance to thyroid hormone |
| RS2471599684 |
THRB
|
Health Risk |
Likely pathogenic |
THRB-related disorder, THRB-related disorder |
| RS2471599939 |
THRB
|
Health Risk |
Likely pathogenic |
— |
| RS2471600433 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471619850 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2471620779 |
MITF
|
Health Risk |
Pathogenic |
Melanoma, cutaneous malignant |
| RS2471621034 |
MITF
|
Health Risk |
Pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471630299 |
IMPDH2
|
Health Risk |
Likely pathogenic |
— |
| RS2471630430 |
MITF
|
Health Risk |
Likely pathogenic |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS2471630671 |
IMPDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
IMPDH2-related neurodevelopmental condition, IMPDH2-related neurodevelopmental condition |
| RS2471632050 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471632340 |
IMPDH2
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Dystonic disorder |
| RS2471632438 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471632647 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471633372 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471636851 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471638084 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2471638168 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471638436 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471641679 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471644439 |
MITF
|
Health Risk |
Likely pathogenic |
Melanoma, Melanoma |
| RS2471649491 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471649600 |
SCN5A
|
Health Risk |
Likely pathogenic |
Congenital long QT syndrome, Congenital long QT syndrome |
| RS2471650207 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471650800 |
QRICH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2471656861 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2471657748 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471657838 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471658799 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471658928 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471658977 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome (shorter-than-normal QT interval), Brugada syndrome (shorter-than-normal QT interval) |
| RS2471659061 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471659309 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471659465 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471659972 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471660729 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471660795 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471673266 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471673344 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471673356 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2471675160 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS2471675336 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471675343 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471675503 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471675648 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471677709 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2471677773 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471677956 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471678625 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2471682518 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471684443 |
SCN5A
|
Health Risk |
Likely pathogenic |
8 conditions, 8 conditions |
| RS2471685074 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471685151 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2471706730 |
QRICH1
|
Health Risk |
Pathogenic |
— |
| RS2471707104 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471707459 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471708259 |
QRICH1
|
Health Risk |
Pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471708593 |
QRICH1
|
Health Risk |
Pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2471710380 |
QRICH1
|
Health Risk |
Pathogenic |
— |
| RS2471718612 |
ROBO1
|
Health Risk |
Pathogenic |
— |
| RS2471720840 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Cardiac arrhythmia |
| RS2471721652 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2471722766 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471722837 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471722852 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471725870 |
THRB
|
Health Risk |
Likely pathogenic |
THRB-related disorder, THRB-related disorder |
| RS2471726839 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2471727098 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2471727144 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS2471727172 |
GBE1
|
Health Risk |
Likely pathogenic |
GBE1-related disorder, GBE1-related disorder |
| RS2471727306 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471727316 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease, type IV |
| RS2471727330 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |